Novavax, Inc.
US ˙ NasdaqGS ˙ US6700024010

SecurityNVAX / Novavax, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership41,657 shares
Latest Disclosed Value $ 305,762
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.48% increase in ownership of NVAX / Novavax, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 41,657 shares of Novavax, Inc. (US:NVAX) valued at $305,762 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 41,457 shares of Novavax, Inc.. This represents a change in shares of 0.48% during the quarter. The current value of the position is $395,325 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP NOVAVAX EC US6700024010 41,657 200 0.48 306 -11.59 0.0040
2025-04-25 2025-02-28 NP NOVAVAX EC US6700024010 41,457 1,080 2.67 345 -1.99 0.0047
2025-01-27 2024-11-30 NP NOVAVAX EC US6700024010 40,377 280 0.70 352 -29.03 0.0048
2024-10-29 2024-08-31 NP NOVAVAX EC US6700024010 40,097 40,097 496 0.0074
2023-10-27 2023-08-31 NP NOVAVAX EC US6700024010 0 -24,637 -100.00 0 -100.00
2023-07-26 2023-05-31 NP NOVAVAX EC US6700024010 24,637 78 0.32 198 -12.78 0.0043
2023-04-27 2023-02-28 NP NOVAVAX EC US6700024010 24,559 585 2.44 227 -42.53 0.0056
2023-01-26 2022-11-30 NP NOVAVAX EC US6700024010 23,974 4,404 22.50 395 -38.85 0.0099
2022-10-26 2022-08-31 NP NOVAVAX EC US6700024010 19,570 4,213 27.43 647 -23.91 0.0162
2022-07-29 2022-05-31 NP NOVAVAX EC US6700024010 15,357 468 3.14 850 -31.59 0.0216
2022-04-28 2022-02-28 NP NOVAVAX EC US6700024010 14,889 234 1.60 1,241 -59.40 0.0288
2022-01-25 2021-11-30 NP NOVAVAX EC US6700024010 14,655 713 5.11 3,057 -8.06 0.0639
2021-10-26 2021-08-31 NP NOVAVAX EC US6700024010 13,942 297 2.18 3,326 65.09 0.0729
2021-07-22 2021-05-31 NP NOVAVAX EC US6700024010 13,645 866 6.78 2,014 -31.82 0.0501
2021-04-23 2021-02-28 NP NOVAVAX EC US6700024010 12,779 -770 -5.68 2,955 56.30 0.0770
2021-01-20 2020-11-30 NP NOVAVAX EC US6700024010 13,549 179 1.34 1,890 28.14 0.0565
2020-10-16 2020-08-31 NP NOVAVAX EC US6700024010 13,370 2,998 28.90 1,475 209.22 0.0455
2020-07-20 2020-05-31 NP NOVAVAX EC US6700024010 10,372 -975 -8.59 478 767.27 0.0186
2020-01-16 2019-11-30 NP NOVAVAX EC US6700024010 11,347 11,347 55 0.0025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.